Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4742-4751

  Mori, Yu ^a,b,c   Tsuji, Sukenao ^a,b   Inui, Masanori ^a,b   Sakamoto, Yuzuru ^a,b   Endo, Shota ^a,b   Ito, Yumi ^a,b   Fujimura, Shion ^a,b   Koga, Takako ^d   Nakamura, Akira ^a,b   Takayanagi, Hiroshi ^d   Itoi, Eiji ^c   Takai, Toshiyuki ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OSTEOCLAST DIFFERENTIATION FACTOR; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR B; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; FC RECEPTOR; GROWTH INHIBITOR; ISOPROTEIN; LEUKOCYTE ANTIGEN; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 3, HUMAN; LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR 3, HUMAN; LILRB1 PROTEIN, HUMAN; LILRB2 PROTEIN, HUMAN; LILRB3 PROTEIN, HUMAN; LILRB4 PROTEIN, HUMAN; MEMBRANE PROTEIN; PIRB PROTEIN, MOUSE; TNFSF11 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STEM CELL; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MONOCYTE MACROPHAGE PRECURSOR CELL; MOUSE MUTANT; OSTEOBLAST; OSTEOPOROSIS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; GROWTH INHIBITORS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTE-MACROPHAGE PRECURSOR CELLS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; PROTEIN ISOFORMS; RANK LIGAND; RECEPTORS, CELL SURFACE; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC;

EID: 58149280845     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4742     Document Type: Article

References (46)

1. Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
2. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357. (Pubitemid 30649812)
3. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
4. Kodama, H., M. Nose, S. Niida, and A. Yamasaki. 1991. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J. Exp. Med. 173: 1291-1294.
5. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901. (Pubitemid 35460788)
6. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
7. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763. (Pubitemid 38508286)
8. Kaifu, T., J. Nakahara, M. Inui, K. Mishima, T. Momiyama, M. Kaji, A. Sugahara, H. Koito, A. Ujike-Asai, A. Nakamura, et al. 2003. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111: 323-332. (Pubitemid 36182208)
9. Humphrey, M. B., K. Ogasawara, W. Yao, S. C. Spusta, M. R. Daws, N. E. Lane, L. L. Lanier, and M. C. Nakamura. 2004. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J. Bone Miner. Res. 19: 224-234.
10. Mocsai, A., M. B. Humphrey, J. A. Van Ziffle, Y. Hu, A. Burghardt, S. C. Spusta, S. Majumdar, L. L. Lanier, C. A. Lowell, and M. C. Nakamura. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 101: 6158-6163. (Pubitemid 38520544)
11. Humphrey, M. B., M. R. Daws, S. C. Spusta, E. C. Niemi, J. A. Torchia, L. L. Lanier, W. E. Seaman, and M. C. Nakamura. 2006. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J. Bone Miner. Res. 21: 237-245. (Pubitemid 43265289)
12. Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, et al. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12: 1260-1268. (Pubitemid 28213402)
13. Takeshita, S., N. Namba, J. J. Zhao, Y. Jiang, H. K. Genant, M. J. Silva, M. D. Brodt, C. D. Helgason, J. Kalesnikoff, M. J. Rauh, et al. 2002. SHIPdeficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8: 943-949. (Pubitemid 35033697)
14. Umeda, S., W. G. Beamer, K. Takagi, M. Naito, S. Hayashi, H. Yonemitsu, T. Yi, and L. D. Shultz. 1999. Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am. J. Pathol. 155: 223-233. (Pubitemid 29318720)
15. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
16. Yogo, K., M. Mizutamari, K. Mishima, H. Takenouchi, N. Ishida-Kitagawa, T. Sasaki, and T. Takeya. 2006. Src homology 2 (SH2)-containing 5′-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts. Endocrinology 147: 3307-3317. (Pubitemid 43901121)
17. Zhang, Z., E. Jimi, and A. L. Bothwell. 2003. Receptor activator of NF-κB ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J. Immunol. 171: 3620-3626. (Pubitemid 37254565)
18. Hayashi, S., M. Tsuneto, T. Yamada, M. Nose, M. Yoshino, L. D. Shultz, and H. Yamazaki. 2004. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice. Endocrinology 145: 2721-2729. (Pubitemid 38686220)
19. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809-1818. (Pubitemid 27524591)
20. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282. (Pubitemid 27392018)
21. Wagtmann, N., S. Rojo, E. Eichler, H. Mohrenweiser, and E. O. Long. 1997. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr. Biol. 7: 615-618. (Pubitemid 27335659)
22. Lienard, H., P. Bruhns, O. Malbec, W. H. Fridman, and M. Daeron. 1999. Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation. J. Biol. Chem. 274: 32493-32499. (Pubitemid 129503855)
23. Hayami, K., D. Fukuta, Y. Nishikawa, Y. Yamashita, M. Inui, Y. Ohyama, M. Hikida, H. Ohmori, and T. Takai. 1997. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J. Biol. Chem. 272: 7320-7327. (Pubitemid 27166441)
24. Kubagawa, H., P. D. Burrows, and M. D. Cooper. 1997. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 94: 5261-5266. (Pubitemid 27214771)
25. Katz, H. R., E. Vivier, M. C. Castells, M. J. McCormick, J. M. Chambers, and K. F. Austen. 1996. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc. Natl. Acad. Sci. USA 93: 10809-10814.
26. Kuroiwa, A., Y. Yamashita, M. Inui, T. Yuasa, M. Ono, A. Nagabukuro, Y. Matsuda, and T. Takai. 1998. Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. J. Biol. Chem. 273: 1070-1074. (Pubitemid 28049206)
27. Coggeshall, K. M., K. Nakamura, and H. Phee. 2002. How do inhibitory phosphatases work? Mol. Immunol. 39: 521-529.
28. Saverino, D., M. Fabbi, F. Ghiotto, A. Merlo, S. Bruno, D. Zarcone, C. Tenca, M. Tiso, G. Santoro, G. Anastasi, et al. 2000. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165: 3742-3755. (Pubitemid 32057280)
29. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290: 84-89.
30. Takai, T. 2005. A novel recognition system for MHC class I molecules constituted by PIR. Adv. Immunol. 88: 161-192. (Pubitemid 41437914)
31. -/- mice. Nat. Immunol. 3: 542-548.
32. Tamir, I., J. M. Dal Porto, and J. C. Cambier. 2000. Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction. Curr. Opin. Immunol. 12: 307-315. (Pubitemid 30240541)
33. Borges, L., and D. Cosman. 2000. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 11: 209-217. (Pubitemid 30337460)
34. Cella, M., C. Dohring, J. Samaridis, M. Dessing, M. Brockhaus, A. Lanzavecchia, and M. Colonna. 1997. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185: 1743-1751. (Pubitemid 27242195)
35. Brown, D., J. Trowsdale, and R. Allen. 2004. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64: 215-225. (Pubitemid 39120446)
36. -/- mice. Nat. Immunol. 5: 623-629.
37. Willcox, B. E., L. M. Thomas, and P. J. Bjorkman. 2003. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4: 913-919.
38. Masuda, A., A. Nakamura, T. Maeda, Y. Sakamoto, and T. Takai. 2007. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J. Exp. Med. 204: 907-920. (Pubitemid 46631618)
39. Horvath, G., M. Petras, G. Szentesi, A. Fabian, J. W. Park, G. Vereb, and J. Szollosi. 2005. Selecting the right fluorophores and flow cytometer for fluorescence resonance energy transfer measurements. Cytometry A 65: 148-157. (Pubitemid 40726867)
40. Ho, L. H., T. Uehara, C. C. Chen, H. Kubagawa, and M. D. Cooper. 1999. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl. Acad. Sci. USA 96: 15086-15090.
41. Takai, T. 2005. Fc receptors and their role in immune regulation and autoimmunity. J. Clin. Immunol. 25: 1-18. (Pubitemid 40386174)
42. Allen, R. L., T. Raine, A. Haude, J. Trowsdale, and M. J. Wilson. 2001. Cutting edge: Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J. Immunol. 167: 5543-5547.
43. Clark, G. J., B. J. Green, and D. N. Hart. 2000. The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17. Tissue Antigens 55: 101-109.
44. Chung, D. H., M. B. Humphrey, M. C. Nakamura, D. G. Ginzinger, W. E. Seaman, and M. R. Daws. 2003. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J. Immunol. 171: 6541-6548.
45. Kuroki, K., N. Tsuchiya, M. Shiroishi, L. Rasubala, Y. Yamashita, K. Matsuta, T. Fukazawa, M. Kusaoi, Y. Murakami, M. Takiguchi, et al. 2005. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum. Mol. Genet. 14: 2469-2480. (Pubitemid 41418008)
46. Heinzmann, A., S. Blattmann, J. Forster, J. Kuehr, and K. A. Deichmann. 2000. Common polymorphisms and alternative splicing in the ILT3 gene are not associated with atopy. Eur. J. Immunogenet. 27: 121-127. (Pubitemid 30450108)